Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2

被引:16
|
作者
Chamorro, Manuel F. [1 ]
Walz, Paul H. [2 ]
Passler, Thomas [1 ]
van Santen, Edzard [4 ,5 ]
Gard, Julie [1 ]
Rodning, Soren P. [3 ]
Riddell, Kay P. [2 ]
Galik, Patricia K. [2 ]
Zhang, Yijing [2 ]
机构
[1] Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36849 USA
[2] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA
[3] Auburn Univ, Coll Agr, Dept Anim Sci, Auburn, AL 36849 USA
[4] Auburn Univ, Coll Agr, Dept Crop Soils & Environm Sci, Auburn, AL 36849 USA
[5] Auburn Univ, Alabama Agr Expt Stn, Auburn, AL 36849 USA
来源
BMC VETERINARY RESEARCH | 2015年 / 11卷
关键词
Early weaning; BVDV; MLV; Vaccine; Antibody titres; Virus; Isolation; Shedding; RESPIRATORY-SYNCYTIAL-VIRUS; MATERNAL ANTIBODIES; IMMUNE-RESPONSES; VACCINATION; PROTECTION; INFECTION; HERPESVIRUS-1; PERFORMANCE; INDUCTION; DISEASE;
D O I
10.1186/s12917-015-0342-8
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Vaccination of young calves against Bovine viral diarrhea virus (BVDV) is desirable in dairy and beef operations to reduce clinical disease and prevent spread of the virus among cattle. Although protection from clinical disease by multivalent, modified-live virus (MLV) vaccines has been demonstrated, the ability of MLV vaccines to prevent viremia and viral shedding in young calves possessing passive immunity is not known. The purpose of this study was to compare the ability of three different MLV vaccines to prevent clinical disease, viremia, and virus shedding in early weaned beef calves possessing maternal immunity that were vaccinated once at 45 days prior to challenge with virulent BVDV 2. Results: At 45 days following vaccination, calves that received vaccines B and C had significantly higher BVDV 1 and BVDV 2 serum antibody titers compared with control calves. Serum antibody titers for BVDV 1 and BVDV 2 were not significantly different between control calves and calves that received vaccine D. Following BVDV 2 challenge, a higher proportion of control calves and calves that received vaccine D presented viremia and shed virus compared with calves that received vaccines B and C. Rectal temperatures and clinical scores were not significantly different between groups at any time period. Calves that received vaccines B and C had significantly higher mean body weights at BVDV 2 challenge and at the end of the study compared with control calves. Conclusions: Moderate to low maternally-derived BVDV antibody levels protected all calves against severe clinical disease after challenge with virulent BVDV 2. Vaccines B and C induced a greater antibody response to BVDV 1 and BVDV 2, and resulted in reduced viremia and virus shedding in vaccinated calves after challenge indicating a greater efficacy in preventing virus transmission and reducing negative effects of viremia.
引用
收藏
页数:9
相关论文
共 42 条
  • [31] Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in three-week-old calves experimentally challenged with BRSV
    Vangeel, I
    Antonis, AFG
    Fluess, M
    Peters, AR
    Harmeyer, SS
    CATTLE PRACTICE, 2005, 13 : 263 - 271
  • [32] Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V
    Vangeel, Ilse
    Ioannou, Faye
    Riegler, Lutz
    Salt, Jeremy S.
    Harmeyer, Silke S.
    VETERINARY JOURNAL, 2009, 179 (01) : 101 - 108
  • [33] Pre-arrival management of newly received beef calves with or without exposure to a persistently infected bovine viral diarrhea virus type I calf affects health, performance, bovine viral diarrhea virus type I titers, and circulating leukocytes
    Richeson, J. T.
    Kegley, E. B.
    JOURNAL OF DAIRY SCIENCE, 2010, 93 : 740 - 740
  • [34] Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b
    Leyh, Randy D.
    Fulton, Robert W.
    Stegner, Jacob E.
    Goodyear, Mark D.
    Witte, Steven B.
    Taylor, Lucas P.
    Johnson, Bill J.
    Step, Douglas L.
    Ridpath, Julia F.
    Holland, Ben P.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2011, 72 (03) : 367 - 375
  • [35] Comparison of single vaccination versus revaccination with a modified-live virus vaccine containing bovine herpesvirus-1, bovine viral diarrhea virus (types 1a and 2a), parainfluenza type 3 virus, and bovine respiratory syncytial virus in the prevention of bovine respiratory disease in cattle
    Step, Douglas L.
    Krehbiel, Clinton R.
    Burciaga-Robles, Luis O.
    Holland, Ben P.
    Fulton, Robert W.
    Confer, Anthony W.
    Bechtol, David T.
    Brister, David L.
    Hutcheson, John P.
    Newcomb, Harold L.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2009, 235 (05): : 580 - 587
  • [36] Cross-Neutralization between Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2 after Vaccination with a BVDV-1a Modified-Live-Vaccine
    Grange, Geromine
    Mindeguia, Marie
    Gisbert, Philippe
    Meyer, Gilles
    VACCINES, 2023, 11 (07)
  • [37] Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains
    Xue, Wenzhi
    Mattick, Debra
    Smith, Linda
    Umbaugh, Jerry
    Trigo, Emilio
    VACCINE, 2010, 29 (01) : 70 - 76
  • [38] Mixed Triple: Allied Viruses in Unique Recent Isolates of Highly Virulent Type 2 Bovine Viral Diarrhea Virus Detected by Deep Sequencing
    Jenckel, Maria
    Hoeper, Dirk
    Schirrmeier, Horst
    Reimann, Ilona
    Goller, Katja V.
    Hoffmann, Bernd
    Beer, Martin
    JOURNAL OF VIROLOGY, 2014, 88 (12) : 6983 - 6992
  • [39] Expression of type I interferon-induced antiviral state and pro-apoptosis markers during experimental infection with low or high virulence bovine viral diarrhea virus in beef calves
    Palomares, Roberto A.
    Walz, Heather G.
    Brock, Kenny V.
    VIRUS RESEARCH, 2013, 173 (02) : 260 - 269
  • [40] Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1
    Draeger, Carolin
    Schroeder, Charlotte
    Koenig, Patricia
    Tegtmeyer, Birthe
    Beer, Martin
    Blome, Sandra
    VACCINE, 2016, 34 (39) : 4666 - 4671